Skip to main content
Log in

Synthesis and Evaluation of the Psychotropic Activity of Framework Derivatives of Alpha-Pyrrolidone

  • Published:
Russian Journal of Bioorganic Chemistry Aims and scope Submit manuscript

Abstract

Derivatives of alpha-pyrrolidone and some derivatives of adamantane possess a wide spectrum of psychotropic activity. The synthesis of adamantane and homoadamantane derivatives of alpha-pyrrolidone and the assessment of their psychotropic activity were performed. A number of framework compounds containing a pyrrolidin-2-one fragment either in the side chain or as part of the framework system were synthesized. N-(Adamantan-1-yl)pyrrolidin-2-one (TIM-2) was obtained by the reaction of 1-bromadamantane with pyrrolidin-2-one. Homoadamantane-fused pyrrolidin-2-one (TIM-1) was obtained from β-dicarbonyl derivatives of homoadamantane. Synthesis of the starting 2-(5-oxohomoadamantyl)acetic acid was carried out by cleavage of the corresponding keto diester or cyanoketo ester of homoadamantane under the conditions of the Holler–Bauer reaction with sonication. Then, the resulting γ-keto acid was introduced into the Leuckart–Wallach reaction to obtain cis-decahydro-4,8:6,10-dimethanocyclononane[b]pyrrol-2(1H)-one (TIM-1). The psychotropic activity of the obtained compounds was evaluated in standard behavioral tests in experimental animals. Compound TIM-2 exhibited pronounced anxiolytic, antidepressant, and nootropic activity. Compound binding assays were performed by molecular docking of the synthesized compounds to the GABA-B receptor, which also showed high binding energies for TIM-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.

Similar content being viewed by others

REFERENCES

  1. Nuss, P., Neuropsychiatr. Dis. Treat., 2015, vol. 11, pp. 165–175. https://doi.org/10.2147/NDT.S58841

    Article  PubMed  PubMed Central  Google Scholar 

  2. Tyurenkov, I.N. and Perfilova, V.N., Eksp. Klin. Farmakol., 2011, vol. 74, no. 2, pp. 47–52. https://doi.org/10.30906/0869-2092-2011-74-2-47-52

    Article  CAS  Google Scholar 

  3. Boonstra, E., Kleijn, R., Colzato, L.S., Alkemade, A., Forstmann, B.U., and Nieuwenhuis, S., Front. Psychol., 2015, vol. 6, p. 1520. https://doi.org/10.3389/fpsyg.2015.01520

    Article  PubMed  PubMed Central  Google Scholar 

  4. Berestovitskaya, V.M., Tyurenkov, I.N., Vasil’eva, O.S., Perfilova, V.N., Ostroglyadov, E.S., and Bagmetova, V.V., Ratsetamy: metody sinteza i biologicheskaya aktivnost’ (Racetams: Methods of Synthesis and Biological Activity), St. Petersburg: Asterion, 2016.

  5. Spasov, A.A., Yakovlev, D.S., Brigadirova, A.A., Maltsev, D.V., and Agatsarskaya, Y.V., Russ. J. Bioorg. Chem., 2019, vol. 45, pp. 76–88. https://doi.org/10.1134/S1068162019020146

    Article  CAS  Google Scholar 

  6. Litvin, E.A., Kolyvanov, G.B., and Zherdev, V.P., Farmakokinet. Farmakodinam., 2012, no. 1, pp. 18–24.

  7. Štimac, A., Šekutor, M., Mlinarić-Majerski, K., Frkanec, L., and Frkanec, R., Molecules, 2017, vol. 22, no. 2, p. 297. https://doi.org/10.3390/molecules22020297

    Article  CAS  PubMed Central  Google Scholar 

  8. Wanka, L., Iqbal, K., and Schreiner, P.R., Chem. Rev., 2013, vol. 113, no. 5, pp. 3516–3604. https://doi.org/10.1021/cr100264t

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Morozov, I.S., Ivanova, I.A., and Lukicheva, T.A., Pharm. Chem. J., 2001, vol. 35, no. 5, pp. 235–238. https://doi.org/10.1023/A:1011905302667

    Article  CAS  Google Scholar 

  10. Artavia, G. and Lamoureux, G., Curr. Med. Chem., 2010, vol. 17, no. 26, pp. 2967–2978. https://doi.org/10.2174/092986710792065027

    Article  PubMed  Google Scholar 

  11. Spilovska, K., Zemek, F., Korabecny, J., Nepovimova, E., Soukup, O., Windisch, M., and Kuca, K., Curr. Med. Chem., 2016, vol. 23, no. 29, pp. 3245–3266. https://doi.org/10.2174/0929867323666160525114026

    Article  CAS  PubMed  Google Scholar 

  12. Spasov, A.A., Khamidova, T.V., Bugaeva, L.I., and Morozov, I.S., Pharm. Chem. J., 2000, vol. 34, no. 1, pp. 1–7. https://doi.org/10.1007/bf02524549

    Article  CAS  Google Scholar 

  13. Shokova, E.A. and Kovalev, V.V., Pharm. Chem. J., 2016, vol. 50, no. 2, pp. 63–75. https://doi.org/10.1007/s11094-016-1400-7

    Article  CAS  Google Scholar 

  14. Liu, J., Obando, D., Liao, V., Lifa, T., and Codd, R., Eur. J. Med. Chem., 2011, vol. 46, no. 6, pp. 1949–1963. https://doi.org/10.1016/j.ejmech.2011.01.047

    Article  CAS  PubMed  Google Scholar 

  15. Sibiryakova, A.E., Shiryaev, V.A., Reznikov, A.N., Kabanova, A.A., and Klimochkin, Y.N., Synthesis, 2019, vol. 51, no. 2, pp. 463–469. https://doi.org/10.1055/s-0037-1610824

    Article  CAS  Google Scholar 

  16. Lavrova, L.N., Shalyminova, Yu.A., Klimova, N.V., and Artsimovich, N.G., Khim.-Farm. Zh., 1982, vol. 16, no. 10, pp. 1197–1201.

    Google Scholar 

  17. Geng, Y., Bush, M., Mosyak, L., Wang, F., and Fan, Q.R., Nature, 2013, vol. 504, no. 7479, pp. 254–259. https://doi.org/10.1038/nature12725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Armarego, W.L.F., Chemical methods used in purification, in Purification of Laboratory Chemicals, Oxford: Butterworth Heinemann Books–Elsevier, 2017, pp. 71–94, 8th ed. ISBN 9780128054574

    Google Scholar 

  19. Tkachenko, I.M., Mankova, P.A., Rybakov, V.B., Golovin, E.V., and Klimochkin, Y.N., Org. Biomol. Chem., 2020, vol. 18, no. 3, pp. 465–478. https://doi.org/10.1039/c9ob02060h

    Article  CAS  PubMed  Google Scholar 

  20. No, B.I., Mokhov, V.M., and Vishnevetskii, E.N., Russ. J. Org. Chem., 2003, vol. 39, no. 8, pp. 1193–1194. https://doi.org/10.1023/b:rujo.0000010194.16138.0b

    Article  CAS  Google Scholar 

  21. Kurkin, D.V., Morkovin, E.I., Osadchenko, N.A., Knyshova, L.P., Bakulin, D.A., Abrosimova, E.E., Gorbunova, Yu.V., and Tyurenkov, I.N., Farm. Farmakol., 2019, vol. 7, no. 5, pp. 291–299. https://doi.org/10.19163/2307-9266-2019-7-5-291-299

    Article  Google Scholar 

  22. Spasov, A.A., Zhukovskaya, O.N., Maltsev, D.V., Miroshnikov, M.V., Skripka, M.O., Sultanova, K.T., and Morkovnik, A.S., Russ. J. Bioorg. Chem., 2020, vol. 46, pp. 107–114. https://doi.org/10.1134/S1068162020010124

    Article  CAS  Google Scholar 

  23. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (Guidelines for Conducting Preclinical Trials of Drugs), Mironov, A.N., Ed., Moscow: Grif i K, 2013, part 1.

Download references

Funding

The synthetic part of the work was carried out with the financial support of the Ministry of Science and Higher Education of the Russian Federation within the framework of the project part of the state assignment (no. 0778-2020-0005).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. A. Bakulin.

Ethics declarations

COMPLIANCE WITH ETHICAL STANDARDS

Statement on the welfare of animals. All studies were carried out in accordance with the Eurasian Economic Union legislation and technical standards for good laboratory practice (GOST (State Standards) 53434-2019 and D 51000.4-2011, Directive 2010/63/ of the European Parliament and Council of the European Union, and the interstate standard (GOST (State Standard) 33044-2014)). The study protocol was approved by the local ethics committee (Regional Research Ethics Committee of the Volgograd oblast, no. 2010–2019 dated April 2, 2019).

Conflict of Interests

The authors declare that they have no conflict of interest.

Additional information

Translated by G. Levit

  Abbreviations: BBB, blood–brain barrier; CNS, central nervous system; EET, extrapolation escape test; EPM, Elevated plus maze; GABA, gamma-aminobutyric acid; PAT, Passive avoidance test; XRD, X-ray diffraction analysis; ANR-10, 4-(adamantan-1-yl)pyrrolidin-2-one; IE-1, 1-(3-hydroxyadamantan-1-yl)-pyrrolidin-2-one; TIM-1, (3aS*,10aS*)-decahydro-4,8:6,10-dimethanocyclononane[b]pyrrol-2(1H)-one; TIM-2, 1-(adamantan-1-yl)pyrrolidin-2-one.

Corresponding author: phone: +7(919)545-33-67.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klimochkin, Y.N., Tkachenko, I.M., Reznikov, A.N. et al. Synthesis and Evaluation of the Psychotropic Activity of Framework Derivatives of Alpha-Pyrrolidone. Russ J Bioorg Chem 47, 1276–1287 (2021). https://doi.org/10.1134/S1068162021060108

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1068162021060108

Keywords:

Navigation